PulseNet (30), the national network for comparing molecular subtypes of common foodborne bacterial pathogens, including E. coli O157 since 1997, has greatly assisted in both identifying outbreaks and linking apparently unrelated outbreaks.
In addition, a higher permissible pricing may act as a partial incentive for the pharmaceutical industry to develop drugs for rare indications, as the incidence and prevalence of these newly discovered molecular subtypes of common cancers approaches that of traditional orphan diseases.
Independent transcriptomic studies have shown that prostate tumors can be categorized into three roughly equally common molecular subtypes with different clinical behavior [1, 2].
Common molecular subtypes have already been identified in many of the cancers before [ 11, 13, 14, 17].
The improvement in our understanding on BC biology associated with the study of the genomic aberrations characterizing the most common molecular subtypes allows us to explore new targets for drug development.
To understand the role of miRNAs in this molecular complexity, we performed miRNA expression analysis in a cohort of molecularly well-characterized human breast cancer cell lines to identify miRNAs associated with the most common molecular subtypes and the most frequent genetic aberrations.
However, pathologic assessments of tumors over time have found the particularly aggressive, and least treatable, triple negative (ER, PR and Her2Neu negative) or basal breast cancer molecular subtype to be common in Asian Indians [ 38, 56].
We took advantage of these distinct molecular subtypes of prostate cancer to investigate common behaviors in the relationship between protein-binding sites and locations of SM breakpoints.
Over the last decade we have witnessed the convergence of two powerful experimental designs toward a common goal of defining the molecular subtypes that underpin the likelihood of a cancer patient responding to treatment in the clinic.
Recent studies have attempted to control for tumor molecular subtypes, recognizing that more aggressive subtypes are more common in younger women.
